These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34018034)

  • 1. Intact plasma quantification of the large therapeutic lipopeptide bulevirtide.
    Sauter M; Blank A; Stoll F; Lutz N; Haefeli WE; Burhenne J
    Anal Bioanal Chem; 2021 Sep; 413(22):5645-5654. PubMed ID: 34018034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of micafungin in human plasma by liquid chromatography-tandem mass spectrometry.
    Cangemi G; Barco S; Bandettini R; Castagnola E
    Anal Bioanal Chem; 2014 Feb; 406(6):1795-8. PubMed ID: 24408301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
    Notari S; Tempestilli M; Fabbri G; Libertone R; Antinori A; Ammassari A; Agrati C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():183-190. PubMed ID: 29276983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study.
    Rezk MR; Basalious EB; Amin ME
    Biomed Chromatogr; 2016 Sep; 30(9):1354-62. PubMed ID: 26821881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS.
    van Seyen M; de Graaff Teulen MJA; van Erp NP; Burger DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():15-24. PubMed ID: 30776611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct quantification of lipopeptide biosurfactants in biological samples via HPLC and UPLC-MS requires sample modification with an organic solvent.
    Biniarz P; Łukaszewicz M
    Appl Microbiol Biotechnol; 2017 Jun; 101(11):4747-4759. PubMed ID: 28432441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.
    Xiong Z; Zhang Y; Qin F; Qin T; Yang S; Li F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2111-6. PubMed ID: 20630813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
    Lindegardh N; Hanpithakpong W; Phakdeeraj A; Singhasivanon P; Farrar J; Hien TT; White NJ; Day NP
    J Chromatogr A; 2008 Dec; 1215(1-2):145-51. PubMed ID: 19026421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients.
    De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2015 Oct; 114():127-32. PubMed ID: 26037161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
    Kromdijk W; Pereira SA; Rosing H; Mulder JW; Beijnen JH; Huitema AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():43-51. PubMed ID: 23411018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urine.
    Jiang H; Demers R; Kandoussi H; Burrell R; Eley T; Kadiyala P; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME; Zeng J
    J Pharm Biomed Anal; 2015 Mar; 107():17-23. PubMed ID: 25562845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
    Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
    PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry.
    Ma Z; Li S; He D; Wang Y; Jiang H; Zhou H; Jin J; Lin N
    Rapid Commun Mass Spectrom; 2020 May; 34(9):e8728. PubMed ID: 31960519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive assay for simultaneous determination of plasma concentrations of valganciclovir and its active metabolite ganciclovir by LC/MS/MS.
    Xu HR; Li XN; Chen WL; Liu GY; Chu NN; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):329-34. PubMed ID: 17126086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
    Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
    Lindegårdh N; Hanpithakpong W; Wattanagoon Y; Singhasivanon P; White NJ; Day NP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):74-83. PubMed ID: 17913596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
    Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
    J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
    Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Alefacept, an immunosuppressive fusion protein in human plasma using a protein analogue internal standard, trypsin cleaved signature peptides and liquid chromatography tandem mass spectrometry.
    Halquist MS; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):789-98. PubMed ID: 21397570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.